In PD models, inhibition of GSK-3β safeguards dopaminergic neurons from stress-induced damage, subsequently reducing dopamine-driven locomotor deficit (Beaulieu et al., 2004; Wang et al., 2007). The gene discussed is GSK3B; the disease is Parkinson disease.